Log inAsahi Kasei
Healthcare Materials Division
The Asahi Kasei Healthcare Materials Division offers microcrystalline
cellulose (MCC) for oral solid dosage forms of
pharmaceuticals and nutraceuticals; and hyaluronic acid nanogel for drug delivery system (DDS)
material mainly for
injection formulations of pharmaceuticals.
A noteworthy advantage of our products is their ability to facilitate challenging and/or
innovative formulations of
pharmaceuticals and nutraceuticals that customers are bringing to market.
Products category
About Asahi Kasei
Three business sectors of Asahi Kasei
Asahi Kasei is a diversified Japanese chemical company with over a century of
history.
We operate in the three business sectors of Material, Homes, and Health Care.
Creating for Tomorrow
The commitment of the Asahi Kasei Group:
To do all that we can in every era to help the people of the world make the most of life
and attain fulfillment in living.
Since our founding, we have always been deeply committed to contributing to the
development of society, boldly anticipating the emergence of new needs.
This is what we mean by “Creating for Tomorrow.”
Nobeoka, Miyazaki, Japan, cradle of Asahi Kasei
News
Events
-
Conference
PBP World Meeting
Date : 18-21 March 2024
Location : Vienna, Austria
Product category : Hyaluronic acid nanogel, Microcrystalline cellulose (MCC)
-
Exhibition
CPHI India
Date : 28-30 November 2023
Location : Delhi NCR, India
Product category : Microcrystalline cellulose (MCC)
-
Exhibition
CPHI Worldwide
Date : 24 - 26 October 2023
Location : Barcelona, Spain
Product category : Microcrystalline cellulose (MCC)
Our booth : 4D20